Markets
markets
Luke Kawa

It sucks to be close to OpenAI right now

There’s a common thread between what’s ailing some different parts of the AI trade right now:

A high-profile relationship with OpenAI is a millstone around your neck. The ChatGPT maker is seemingly getting bested by Google’s Gemini 3 (and knows it) while burning a lot of cash, with no end to the red ink in sight.

Such millstone-afflicted parties include:

  • Investing conglomerate SoftBank has tumbled 9.9% and 10.8% in its two most recent trading days in Japan. SoftBank is a useful way to express a view on how OpenAI is doing because the Masayoshi Son-led firm is poised to own about 11% of the company, and increases in its valuation have been a big driver of SoftBank’s growth in net income. SoftBank sold its entire $5.8 billion stake in Nvidia in October, likely to finance what it owes OpenAI to build its position in that privately held company.

  • Oracle has the dubious distinction of getting battered across two different asset classes thanks to OpenAI. Remember: traders loved Oracle’s massive cloud-revenue backlog in the abstract. When the specifics were revealed and much of that sales pipeline was down to a $300 billion deal with OpenAI, that was when the stock peaked. More recently, credit default swaps tied to Oracle’s debt have also widened significantly, as the company’s infrastructure build-out is launching to fulfill demand from OpenAI, a customer that’s considered to be significantly less creditworthy.

  • The AI chip business of Advanced Micro Devices had a major breakthrough in October, securing a deal to sell multiple generations of its flagship GPUs for “tens of billions” in revenue. But... OpenAI was once again the customer. This was quickly followed by a separate announcement that 50,000 of its AI chips would be deployed in data centers run by Oracle starting in the second half of next year, likely de facto representing a further enmeshing of its relationship with OpenAI.

  • Microsoft has a tighter partnership with and bigger equity position in OpenAI than SoftBank. On the other hand, it also has its own successful core business, which significantly dilutes any OpenAI “signal,” so to speak. It’s the second-worst publicly traded hyperscaler in November, down almost double digits and trailing only Oracle.

More Markets

See all Markets
markets

Sandisk rides Wall Street price target hikes toward new record

Sandisk leapt Friday, riding a resurgent wave of AI-related market exuberance as well as two price target hikes from Wall Street analysts.

Goldman Sachs lifted its target for the stock to $320 from $280, while keeping a “buy” rating on the stock. Mizhuho lifted its target to a Street high of $410 from its previous target of $250, while maintaining an “outperform” rating on the shares.

Long considered a maker of commodity data storage products, Sandisk was spun off by Western Digital in an IPO in February.

When it dawned on the market sometime in the fall that the AI boom would mean an explosion in demand for data storage, Sandisk shares went parabolic.

Its more than 350% run-up between the ends of August and December led to Sandisk’s inclusion in the S&P 500. And its 560% gain for the year made it the index’s top performer.

markets

It looks like the stock market was expecting some tariff relief

The S&P 500 briefly dipped into negative territory and tariff-sensitive stocks swung from big gains to big losses after the Supreme Court declined to give a ruling on tariffs imposed by President Donald Trump under the IEEPA.

A basket of “Trump Tariff Losers” stocks compiled by UBS, which includes Under Armour, American Eagle, Yeti, Mattel, and Deckers Outdoor, was up as much as 1.5% in early trading before falling as much as 1.7% after news of the lack of news surfaced.

The good news is that for the market as a whole (and even this group in particular), the pain seems to have been short-lived, with both bouncing back to erase losses.

It’s a decent little snapshot or case study to show that, yes, as prediction markets imply, the stock market is pricing in tariff relief.

markets

Amazon pharmacy to begin offering home delivery for Novo Nordisk’s Wegovy pill

Amazon Pharmacy announced Friday that it will offer Novo Nordisk’s recently approved weight-loss pill Wegovy, the newest frontier in the drugmaker’s push toward direct-to-consumer options.

Amazon said it will offer delivery for the pill through insurance and cash-pay options. Novos cash-pay price for the pill is $149 a month — less than half of what its injectables cost through the same channel.

Novo has partnered with big-box stores like Costco and Walmart as well as several big telehealth companies, including Ro, Weight Watchers, and LifeMD, to distribute the pill. This comes as the Danish pharma giant is trying to regain ground after Eli Lilly surpassed it in market share, in large part because of its early emphasis on direct-to-consumer channels.

The Food and Drug Administration approved Novos weight-loss pill in December, making it the first approved weight-loss pill to go to market. It has the same active ingredient, semaglutide, as its injectable products, Ozempic and Wegovy. Lillys oral version, orforglipron, is expected to come to market later this year.

markets

Intel gains after a favorable post from Trump

Intel continued its strong 2026 start by rising early Friday, following a favorable online post from President Trump, whose administration partially nationalized the ailing American chip giant in August.

In a Truth Social post Thursday afternoon, he praised CEO Lip-Bu Tan, boasted about the amount of money the government’s 10% investment in the company has made, and said, “Our Country is determined to bring leading edge Chip Manufacturing back to America, and that is exactly what is happening!!!”

Even after adjusting for the Trumpian tendency toward hyperbole, that last comment will be intriguing to Intel watchers. The company’s search to make deals with external customers willing to use its next-generation contract chip manufacturing business, crucial to the future of Intel’s ailing foundry business, will likely be a key driver of the stock price this year.

It’s not nuts to think that having the US government as a shareholder and the president as an active cheerleader — especially one who’s not shy about putting pressure on private sector companies to get what he wants — could be helpful in corralling reticent foundry customers.

Intel is up roughly 16% year to date and has more than doubled over the last year.

Even after adjusting for the Trumpian tendency toward hyperbole, that last comment will be intriguing to Intel watchers. The company’s search to make deals with external customers willing to use its next-generation contract chip manufacturing business, crucial to the future of Intel’s ailing foundry business, will likely be a key driver of the stock price this year.

It’s not nuts to think that having the US government as a shareholder and the president as an active cheerleader — especially one who’s not shy about putting pressure on private sector companies to get what he wants — could be helpful in corralling reticent foundry customers.

Intel is up roughly 16% year to date and has more than doubled over the last year.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.